Vetter’s Skokie Facility Expansion Nears Completion

Facility growth is necessary to help meet customer demands and new
product requirements

SKOKIE, Ill. & RAVENSBURG, Germany–(BUSINESS WIRE)–

• Demonstration of consistent strategy to stay at the forefront in
  the market
• Expansions will help meet an increase in customer projects
• A second extension is in the final planning stage

Vetter,
a global operating Contract Development and Manufacturing Organization
(CDMO) announced today that a significant level of expansion activities
are nearing completion at its US clinical manufacturing facility located
at the Illinois Science & Technology Park in suburban Chicago. The
ongoing growth of the facility will help satisfy existing and
ever-increasing future customer requirements as well enable meet the
complex needs of newer drug molecules like peptides or antibodies, many
which need refrigeration or freezing. New offices with 45 work stations,
conference rooms and an archive room are also included. To support the
increase in customer projects, a permanent second work shift will be
added in Visual Inspection over the next months. A second shift in
Quality Oversight is also planned. “This variety of activities is a
further proof point of Vetter’s consistent strategic approach to stay
ahead of the market by focusing on the important service needs of our
customers during their drug
development journey; promptness; flexibility; high yield of their
valuable API and, of course high quality,” explains Dr. Claus Feussner,
Senior Vice President of Vetter Development Service.

Since beginning full operations in late 2011, Vetter’s US early-stage
development site has been expanding to help meet growing customer
demands. As recently as 2016, the site expanded its storage capacity by
150 percent to 3,700 sq. ft. With the new additions, most of which are
expected to be completed by April, the site will increase its storage
space by an additional 3,100 sq. ft. The new storage includes a 2,500
sq. ft. freezer farm as well as a planned 600 sq. ft. walk-in
refrigerator. In total, 6,800 sq. ft. of storage space will result. A
second extension, now in the final planning stage, will include an
additional 1,500 sq. ft. of room temperature and freezer space. “When
completed, the facility will have more than double the overall storage
space we have currently available. This extensive expansion of freezer
and refrigeration storage space represents the ongoing evolution in our
Chicago business,” summarizes Dr. Susanne Lemaine, Vice President Vetter
Development Service Chicago.

Find the Vetter press kit and more background information here

About Vetter

Headquartered in Ravensburg, Germany, Vetter is a global leading
contract development and manufacturing organization (CDMO) with
production facilities in Germany and the United States. Currently
employing 4,500
individuals worldwide, the company has long-term experience in
supporting biotechnology and pharmaceutical customers both large and
small. Vetter services
range from early stage development support including clinical
manufacturing, to commercial
supply and numerous
packaging solutions for vials, syringes and cartridges. As a leading
solution provider, Vetter appreciates its responsibility to support the
needs of its customers by developing devices that contribute to
increased patient safety, convenience, and enhanced compliance. Great
importance is also given to social
responsibility including environmental
protection and sustainability. Learn more about Vetter at www.vetter-pharma.com.

Contacts

Vetter Pharma International GmbH
Markus Kirchner
Corporate
Spokesperson / Media Relations
Phone: +49 (0)751-3700-3729
E-mail:
[email protected]